Systemic Therapeutics Corp. is a Canadian pre-clinical stage, biotechnology company specialized in the development of new therapies focusing on the master regulator of lipid metabolism, sterol regulatory-element binding proteins (SREBP), based on first-in-class small molecule SREBP inhibitors. The company aims to provide new treatment options for metabolic conditions such as dyslipidemia, via reduction of circulating PCSK9, and Non-Alcoholic Fatty Liver Disease. Systemic is pioneering a new approach to the care of metabolic disorders.
Co-Founder, Executive Chairman and Chief Scientific Officer
Co-Founder and Vice President, Drug Discovery
Co-Founder and Chief Medical Officer
Co-Founder and Vice President, Business Development
Intellectual Property
Fundraising
Support and celebrate the achievements of women in business and entrepreneurship. HERhalton by Innovation Factory is the region’s go-to networking event for advocates of women entrepreneurs and features engaging guest speakers to inspire and drive engaging conversation.
Expand your network and connect with the region’s influencers and innovators in the world of women in business
March 13, 2025 | 8:00am – 12:00pm EDT
